Carminomycin
目录号 : GC14964antitumor antibiotic
Cas No.:50935-04-1,39472-31-6
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Carminomycin is a new antitumor antibiotic [1].
Antibiotics are a type of antimicrobial used in the treatment of bacterial infection. They can inhibit the growth of bacteria. Antitumor antibiotics are effective agents widely used in cancer chemotherapy [2].
Carminomycin is a new antitumor antibiotic isolated from the mycelium of Actinomadura carminata containing seven components, five of which are biologically active. The more interesting components are components 1, 2 and 3 [1]. In human MCF-7 breast carcinoma and human K562 leukemia cell lines, carminomycin inhibited cell growth with IC50 values of 90 and 60 nM, respectively. In Pgp-expressing MCF-7Dox and K562i/S9 cell lines, carminomycin inhibited cell growth with a similar activity compared with wild type cells, which suggested that carminomycin could circumvent Pgp-mediated multidrug resistant (MDR) [2]. In Micrococcus luteus cells, carminomycin induced one-thread breaks in DNA. In mutant strain DB-7 of M. luteus, carminomycin was more difficult to induce the one-thread breaks, suggesting that UV-endonuclease was probably involved in reparation of the DNA damages induced by carminomycin [3].
In DBA/2 mice with leukemia L-1210, carminomycin (1.5 mg/kg) inhibited the lymphoma colonies by 50% [4].
References:
[1]. Brazhnikova MG, Zbarsky VB, Ponomarenko VI, et al. Physical and chemical characteristics and structure of carminomycin, a new antitumor antibiotic. J Antibiot (Tokyo), 1974, 27(4): 254-259.
[2]. Tevyashova AN, Shtil AA, Olsufyeva EN, et al. Carminomycin, 14-hydroxycarminomycin and its novel carbohydrate derivatives potently kill human tumor cells and their multidrug resistant variants. J Antibiot (Tokyo), 2004, 57(2): 143-150.
[3]. Trenin AS. Carminomycin induction of single-stranded DNA breaks in Micrococcus luteus cells. Antibiotiki, 1979, 24(11): 841-846.
[4]. Berezina TA, Uteshev BS. Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model. Antibiotiki, 1979, 24(10): 767-771.
Cas No. | 50935-04-1,39472-31-6 | SDF | |
化学名 | (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,6,8,11-tetrahydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione | ||
Canonical SMILES | C[C@@]1([H])[C@](O)([H])[C@](N)([H])C[C@@](O[C@@]2([H])C[C@@](C(C)=O)(O)CC(C2=C3O)=C(O)C4=C3C(C5=C(C4=O)C=CC=C5O)=O)([H])O1 | ||
分子式 | C26H27NO10 | 分子量 | 513.49 |
溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.9475 mL | 9.7373 mL | 19.4746 mL |
5 mM | 0.3895 mL | 1.9475 mL | 3.8949 mL |
10 mM | 0.1947 mL | 0.9737 mL | 1.9475 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。